(相关资料图)

纳斯达克生物科技指数收涨0.05%，成分股Fulcrum Therapeutics收涨38.52%，诺瓦瓦克斯医药(NVAX)涨13.51%，Kezar Life、Humacyte、Crinetics Pharma、亘喜生物A(150257)DR(GRCL)、Eiger BioPharmaceuticals、Axsome Therapeutics、Poseida Therapeutics Inc.涨9.38%-5.44%，BioNTech涨5.35%，Centessa Pharmaceuticals则收跌6.02%，PepGen、Karyopharm Therapeutics、Absci、23Andme Holding Co.跌6.82%-9.65%，Alaunos Therapeutics跌11.13%，Allovir跌12.91%，杰龙(GERN)跌13.31%